LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 1209 | 860 | 4093 | 0.2101 | -0.1763 |
MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 1209 | 995 | 4121 | 0.2414 | -0.1045 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 1209 | 1597 | 3823 | 0.4177 | 0.1822 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 1209 | 1619 | 4093 | 0.3955 | 0.1803 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 1209 | 1710 | 4121 | 0.4149 | 0.2163 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1209 | 2912 | 3980 | 0.7317 | 0.6675 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1209 | 3368 | 4252 | 0.7920 | 0.7587 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1209 | 3338 | 4376 | 0.7628 | 0.7284 |
MCF7 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1209 | 1357 | 3823 | 0.3550 | 0.0717 |
MCF7 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1209 | 1625 | 4093 | 0.3969 | 0.1828 |
MCF7 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1209 | 1582 | 4121 | 0.3839 | 0.1639 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1209 | 2313 | 3980 | 0.5812 | 0.4583 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1209 | 2272 | 4252 | 0.5342 | 0.4156 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1209 | 2190 | 4376 | 0.5004 | 0.3771 |
MCF7 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1209 | 1723 | 3823 | 0.4507 | 0.2375 |
MCF7 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1209 | 1683 | 4093 | 0.4111 | 0.2066 |
MCF7 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1209 | 1609 | 4121 | 0.3904 | 0.1751 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1209 | 1693 | 3980 | 0.4254 | 0.2161 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1209 | 1686 | 4252 | 0.3965 | 0.2009 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1209 | 1529 | 4376 | 0.3494 | 0.1347 |
MCF7 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1209 | 1622 | 3823 | 0.4243 | 0.1933 |
MCF7 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1209 | 1526 | 4093 | 0.3728 | 0.1412 |
MCF7 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1209 | 1625 | 4121 | 0.3943 | 0.1817 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1209 | 1390 | 3980 | 0.3492 | 0.0843 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 1209 | 1516 | 4252 | 0.3565 | 0.1326 |